¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

(3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04
±³À°ÀÏÀÚ : 2024-05-04
±³À°Àå¼Ò : ½ÅÈ­¿ùµå ·£µùÄÁº¥¼Ç  

±³À°ÁÖÁ¦ : (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ
´ã´çÀÚ : °­°æ·¡
¿¬¶ôó : 070-7558-2608  

À̸ÞÀÏ : kterms@gmail.com

±³À°Á¾·ù : ³»°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, À̺ñÀÎÈÄ°ú, ºñ´¢ÀÇÇаú, ½Å°æ°ú, ºÐÀÚ»ý¹°ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 310,000¿ø  

ºñ°í ÀϹÝÁ¤È¸¿ø »çÀüµî·Ï: 22¸¸¿ø / ÀϹÝÁ¤È¸¿ø ÇöÀåµî·Ï: 26¸¸¿ø / ÀϹݺñȸ¿ø »çÀüµî·Ï: 27¸¸¿ø / ÀϹݺñȸ¿ø ÇöÀåµî·Ï: 31¸¸¿ø / ÇлýÁ¤È¸¿ø »çÀüµî·Ï: 9¸¸¿ø / ÇлýÁ¤È¸¿ø ÇöÀåµî·Ï: 11¸¸¿ø / Çлýºñȸ¿ø »çÀüµî·Ï: 1¸¸¿ø / Çлýºñȸ¿ø ÇöÀåµî·Ï: 12¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 09:00~09:25 Exosome-mediated CRISPR/ Cas-based Epigenome Editing in  Alzheimer's Disease Á¶µ¿±Ô(¼º±Õ°ü´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 09:25~09:50 Exosome Surface Glycan Targeting  Lectin Nanoparticles for the  Theragnosis of Tumor ÃÖÁ¾ÈÆ(Áß¾Ó´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 09:50~10:15 Microbial Nano Vesicles (MNV) for  Treatment of Inflammatory Diseases Ãֱ⿵(°­¸ª¿øÁÖ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 10:15~10:40 Patient-derived Microphysiological  Systems to Reconstruct Tumor  Microenvironments °íÁöÈÆ(°¡Ãµ)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 10:40~11:05 Development of Organoid Chip for  Liquid Biopsy Diagnostic Markers ¼Û¿µÁØ(ÀÎõ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM A 11:05~11:30 Understanding the Forces that Control  Cell Fate and Disease Progression  Using Patient-derived Organoids Ȳ¿ë¼º(¼øõÇâ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 09:00~09:25 The Role of Astrocytes and  Collagen in Non-Human Primate  Photothrombosis-Induced Stroke  Model: Functional Recovery from  Neurological Damage Utilizing H2O2  Scavenger À¯½ÂÁØ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 09:25~09:50 Development of Cultured Food Utilizing  Muscle Regeneration Technology for  Preventing Sarcopenia ÃÖÁ¤¼®(ÃæºÏ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 09:50~10:15 Enhanced Intervertebral Disc Repair  and Regeneration Using a Nanohybrid  Peptide Hydrogel ÇÑÀκ¸(Â÷ÀÇ°ú´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 10:15~10:40 Translational Medicine and Companion  Animal Clinical Study ±¸¹Î(VET STEM SOLUTION)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 10:40~11:05 Safety and Efficacy of I.V. Administration   of Allo-Mesenchymal Stem Cells in Companion Animal Patients  ±èÀÇÁø(¸ÞµðÆê µ¿¹°º´¿ø, °Ç±¹´ëÇб³ ºÎ¼Ó  µ¿¹°º´¿ø µ¿¹° Áٱ⼼Æ÷ Ä¡·á ¼¾ÅÍÀå)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM B 11:05~11:30 Stem Cell Research in Veterinary  Medicine ÀÌÇýÁ¤(³ó¸²Ãà»ê°Ë¿ªº»ºÎ ¼öÀÇ¿¬±¸»ç)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 09:00~09:25 Ovary Engineering Using Stem Cells ±èÀ±¿µ(¼­¿ï´ëÇб³º´)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 09:25~09:50 The Clinical Unmet Need for Tissue  Engineering and Regenerative  Medicine in Female Reproduction ±è¿ëÁø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 09:50~10:15 Development of Endometrial Tissue  Assembly for Lego-like Customizable  Tissue Regeneration È«Àμ±(°¡Ãµ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 10:15~10:40 CADASIL: A Genetic Cause of Stroke ÃÖÀçö(Á¦ÁÖÀÇ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 10:40~11:05 Vascular Gemotry and Stroke; What  We Know and Need ±è¹üÁØ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 04ÀÏ ROOM C 11:05~11:30 Tissue Engineering in a Neurovascular  Unit ±èÄ¡°æ(°í·ÁÀÇ´ë)

±âŸ 05¿ù 04ÀÏ ROOM B 11:30~12:00 Award Ceremony & Closing Remark ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦ÁÖÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-08
´ÙÀ½±Û (2ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 2 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 2 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 0 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 2 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 0 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 2 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 2 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 0 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 2 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 2 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷